Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings Meeting Abstract
| Authors: | Lyou, Y.; Grivas, P.; Rosenberg, J. E.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; Burris, H. A. 3rd; Rearden, J.; Andresen, C.; Wang, H.; Daneshmand, S.; Bajorin, D. F.; Pal, S. K. |
| Abstract Title: | Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368302294 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.5038 |
| Notes: | Meeting Abstract: 5038 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work